Literature DB >> 9973160

Circulating interleukin-16 in systemic lupus erythematosus.

S Lee1, H Kaneko, I Sekigawa, Y Tokano, Y Takasaki, H Hashimoto.   

Abstract

OBJECTIVE: To investigate the relationship between interleukin (IL)-16 and systemic lupus erythematosus (SLE).
METHODS: Serum levels of IL-16 were examined in SLE patients using an enzyme-linked immunosorbent assay (ELISA).
RESULTS: The serum level of IL-16 in the patients was much higher than that in healthy volunteers (P < 0.001). An increase in IL-16 was observed in proportion to the activity of SLE assessed by the SLE Disease Activity Index (SLEDAI) score (P < 0.0001).
CONCLUSIONS: Our observations suggest an interaction between disease activity and the production of IL-16 in SLE, and reveal that IL-16 is a useful indicator of disease activity. This is the first report describing the relationship between IL-16 and SLE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9973160     DOI: 10.1093/rheumatology/37.12.1334

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  20 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

2.  Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells.

Authors:  H Ogasawara; N Takeda-Hirokawa; I Sekigawa; H Hashimoto; Y Kaneko; S Hirose
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

3.  Transient elevation of interleukin-16 levels at the initial stage of meningitis in children.

Authors:  T Suzuki; A Ishiguro; T Shimbo
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

6.  Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.

Authors:  Catherine A Thornton; Judith A Holloway; Janis K Shute; John W Holloway; Norma D Diaper; John O Warner
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

7.  Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.

Authors:  Toshio Naito; Hitoshi Ogasawara; Hiroshi Kaneko; Takashi Hishikawa; Iwao Sekigawa; Hiroshi Hashimoto; Naoki Maruyama
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

8.  IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.

Authors:  Siobhan Smith; Pei Wen Wu; Jane J Seo; Thilini Fernando; Mengyao Jin; Jorge Contreras; Erica N Montano; Joan Ní Gabhann; Kyle Cunningham; Amro Widaa; Eoghan M McCarthy; Eamonn S Molloy; Grainne Kearns; Conor C Murphy; Weiping Kong; Harry Björkbacka; Hardy Kornfeld; Lindsy Forbess; Swamy Venuturupalli; Mariko Ishimori; Daniel Wallace; Michael H Weisman; Caroline A Jefferies
Journal:  JCI Insight       Date:  2018-08-09

9.  Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Authors:  Edilberto Postól; André Meyer; Fabíola Cardillo; Raquel de Alencar; Daniel Pessina; Jorge Nihei; Mário Mariano; José Mengel
Journal:  Immunology       Date:  2008-04-07       Impact factor: 7.397

10.  Integrative omics approach identifies interleukin-16 as a biomarker of emphysema.

Authors:  Russell P Bowler; Timothy M Bahr; Grant Hughes; Sharon Lutz; Yu-Il Kim; Christopher D Coldren; Nichole Reisdorph; Katerina J Kechris
Journal:  OMICS       Date:  2013-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.